AI Article Synopsis

  • The study investigates the development of Spasmolytic polypeptide-expressing metaplasia (SPEM) in mice and humans, focusing on parietal cell loss and its implications as a preneoplastic lesion.
  • Differences in RNA transcript patterns among SPEM from various mouse models were analyzed using gene microarrays and validated with PCR, highlighting key proteins like clusterin and CFTR.
  • Results showed that clusterin is consistently upregulated in all SPEM lineages and links to poor survival in gastric cancer, while CFTR expression is specific to inflamed SPEM, suggesting a progression towards a more intestinal-like metaplastic phenotype in inflamed conditions.

Article Abstract

Objectives: Spasmolytic polypeptide-expressing metaplasia (SPEM) develops as a preneoplastic lesion in the stomachs of mice and humans after parietal cell loss. To identify the commonalities and differences between phenotypic SPEM lineages, SPEM were studied from three different mouse models of parietal cell loss: with chronic inflammation with Helicobacter felis infection; with acute inflammation with L635 treatment; and without inflammation following DMP-777 treatment.

Design: RNA transcripts from laser capture microdissected normal chief cells and SPEM lineages were compared using gene microarray. Alterations in transcripts were validated by quantitative real-time PCR. Clusterin and cystic fibrosis transmembrane conductance regulator (CFTR) were selected for immunohistochemical analysis in all mouse models as well as in human SPEM, intestinal metaplasia and gastric cancer.

Results: Transcript expression patterns demonstrated differences among the phenotypic SPEM models. Clusterin expression was significantly upregulated in all three mouse SPEM models as well as in human SPEM. The highest clusterin expression in human gastric cancers correlated with poor survival. Conversely, CFTR expression was upregulated only in SPEM with inflammation in mice. In humans, intestinal metaplasia, but not SPEM, expressed CFTR.

Conclusions: While markers such as clusterin are expressed in all phenotypic SPEM lineages, distinct patterns of upregulated genes including CFTR are present in murine metaplasia associated with inflammation, indicative of progression of metaplasia towards a more intestinalised metaplastic phenotype.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762676PMC
http://dx.doi.org/10.1136/gutjnl-2012-302401DOI Listing

Publication Analysis

Top Keywords

phenotypic spem
12
spem lineages
12
spem
11
spasmolytic polypeptide-expressing
8
polypeptide-expressing metaplasia
8
metaplasia spem
8
mice humans
8
parietal cell
8
cell loss
8
differences phenotypic
8

Similar Publications

Background: Neurological soft signs (NSSs), minor physical anomalies (MPAs), and oculomotor abnormalities were plausible biomarkers in bipolar disorder (BD). However, specific impairments in these markers in patients after the first episode mania (FEM), in comparison with first-degree relatives (high risk [HR]) of BD and healthy subjects (health control [HC]) are sparse.

Aim Of The Study: This study aimed at examining NSSs, MPAs, and oculomotor abnormalities in remitted adult subjects following FEM and HR subjects in comparison with matched healthy controls.

View Article and Find Full Text PDF
Article Synopsis
  • Intraductal Papillary Mucinous Neoplasms (IPMNs) are identified as precursors to pancreatic cancer, and this study explores their connection to pyloric markers and their molecular drivers.
  • The research involved analyzing RNA sequencing data from IPMNs and validating findings through immunostaining in patient samples, revealing that certain oncogenes influence the expression of pyloric markers.
  • Key transcription factors such as SPDEF were identified as playing a crucial role in driving the mucinous characteristics of IPMNs, indicating a potential link between these lesions and gastric epithelial changes.
View Article and Find Full Text PDF

Oculomotor impairments in Parkinson's disease.

Front Aging Neurosci

November 2022

Department of Neurology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Objective: Reliable electrophysiological indicators are urgently needed in the precise evaluation of Parkinson's disease (PD). It is still elusive whether oculomotor performance is impaired or has clinical value in early PD. This study aims to explore oculomotor performance in newly diagnosed, drug-naïve PD and its correlation with clinical phenotype.

View Article and Find Full Text PDF

WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury.

Gastroenterology

September 2021

Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea. Electronic address:

Background & Aims: WAP 4-disulfide core domain protein 2 (WFDC2), also known as human epididymis protein 4, is a small secretory protein that is highly expressed in fibrosis and human cancers, particularly in the ovaries, lungs, and stomach. However, the role of WFDC2 in carcinogenesis is not fully understood. The present study aimed to investigate the role of WFDC2 in gastric carcinogenesis with the use of preneoplastic metaplasia models.

View Article and Find Full Text PDF

Background & Aims: Chronic atrophic gastritis can lead to gastric metaplasia and increase risk of gastric adenocarcinoma. Metaplasia is a precancerous lesion associated with an increased risk for carcinogenesis, but the mechanism(s) by which inflammation induces metaplasia are poorly understood. We investigated transcriptional programs in mucous neck cells and chief cells as they progress to metaplasia mice with chronic gastritis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!